2/27
08:44 am
RVMD
Revolution Medicines (RVMD) is now covered by UBS Group AG. They set a "buy" rating and a $145.00 price target on the stock.
Low
Report
Revolution Medicines (RVMD) is now covered by UBS Group AG. They set a "buy" rating and a $145.00 price target on the stock.
2/26
10:59 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
2/26
10:59 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
2/26
08:10 am
RVMD
Rating for RVMD
Medium
Report
Rating for RVMD
2/26
08:10 am
RVMD
Rating for RVMD
Medium
Report
Rating for RVMD
2/25
07:59 am
RVMD
Revolution Medicines initiated with an Outperform at Evercore ISI
Low
Report
Revolution Medicines initiated with an Outperform at Evercore ISI
2/25
07:59 am
RVMD
Revolution Medicines initiated with an Outperform at Evercore ISI
Low
Report
Revolution Medicines initiated with an Outperform at Evercore ISI
2/17
08:42 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..
Medium
Report
Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..
2/17
08:42 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..
Medium
Report
Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..
2/2
01:00 pm
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/27
09:11 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/27
09:11 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/27
08:08 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
1/22
08:51 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/21
09:25 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/21
09:25 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/21
07:17 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/21
07:17 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/20
09:10 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/20
09:10 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/20
08:11 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/20
08:11 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/13
08:32 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/13
08:32 am
RVMD
Rating for RVMD
Low
Report
Rating for RVMD
1/9
09:14 am
RVMD
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.
Medium
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.